Neuracle
PrivateMomentum
Top 25%
of companies Caplight tracks
Company Overview
Neuracle is a medical devices company that develops and manufactures brain-computer interface (BCI) systems and related equipment for neuroscience research and clinical applications.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment, Health IoT
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neuracle Comparables
Compare Neuracle with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NeuraMatrix | 87% | |
| NeuroXess | 85% | |
| NeuCyber NeuroTech (Beijing) Co., Ltd. | 84% | |
Neuracle Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Open roles doubled to 12, representing 67% of headcount.
- Jul 25, 2026
Monthly visitors increased 59% MoM.
Neuracle Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Neuracle's valuation, stock price, and market status.